Trials / Completed
CompletedNCT03956615
sdAb-based TRNT of Multiple Myeloma: a Feasibility Study
sdAb-based Targeted Radionuclide Therapy of Multiple Myeloma: a Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to show that antiidiotypic sdAb are a new, sensitive, specific and non-invasive tool for imaging and therapeutic purposes and provides a rationale for their clinical evaluation as a personalized treatment option for MM patients expressing surface paraprotein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sampling and bone marrow analysis | Bone marrow sample analysis. A blood sampling of maximally 10 ml by venous puncture (serum) |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2019-05-21
- Last updated
- 2021-12-01
- Results posted
- 2021-12-01
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03956615. Inclusion in this directory is not an endorsement.